RIGEL PHARMACEUTICALS INC
RIGLCIK 0001034842 · Every Form 4 filed by insiders at this issuer.
Filings
12
Latest Mar 29, 2024
Unique insiders
5
Showing
12 of 12
Page 1
Top insiders
Most active reporters at RIGEL PHARMACEUTICALS INC
| Name | Roles | Filings |
|---|---|---|
| RODRIGUEZ RAUL R | OfficerDirector | 3 |
| Santos David A | Officer | 3 |
| Schorno Dean L | Officer | 3 |
| Furey Raymond J. | Officer | 2 |
| Rojkjaer Lisa | Officer | 1 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 29, 2024 | Rojkjaer Lisa EVP, Chief Medical Officer | Holdings only | — | — | — | |
| Mar 1, 2024 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Holdings only | — | — | — | |
| Mar 1, 2024 | RODRIGUEZ RAUL R CEO, President · Director | Holdings only | — | — | — | |
| Mar 1, 2024 | Santos David A EVP, Chief Commercial Officer | Holdings only | — | — | — | |
| Mar 1, 2024 | Schorno Dean L EVP & Chief Financial Officer | Holdings only | — | — | — | |
| Feb 6, 2024 | RODRIGUEZ RAUL R CEO, President · Director | S | 30,545 | $1.14 | $34,821 | |
| Feb 6, 2024 | Schorno Dean L EVP & Chief Financial Officer | S | 7,027 | $1.14 | $8,011 | |
| Feb 6, 2024 | Santos David A EVP, Chief Commercial Officer | S | 8,918 | $1.14 | $10,167 | |
| Jan 25, 2024 | Schorno Dean L EVP & Chief Financial Officer | A | 209,000 | $0.00 | $0 | |
| Jan 25, 2024 | Santos David A EVP, Chief Commercial Officer | A | 209,000 | $0.00 | $0 | |
| Jan 25, 2024 | RODRIGUEZ RAUL R CEO, President · Director | A | 400,000 | $0.00 | $0 | |
| Jan 25, 2024 | Furey Raymond J. EVP, GC, CCO & Corp Sec | A | 209,000 | $0.00 | $0 |
Showing 1–12 of 12
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.